PMN260 / ProMIS Neurosci - LARVOL DELTA

ProMIS Neurosciences to Present Data on ALS & Parkinsons Disease Programs at Alzheimer’s Disease/Parkinson’s Disease 2026 International Conference (AD/PD) (Yahoo Finance) - "The posters will highlight ongoing research related to the Company’s proprietary discovery platform and its approach to selectively targeting toxic misfolded proteins in neurodegenerative diseases....'These data highlight two of our pipeline candidates and underscore our focus on advancing novel therapeutic approaches for ALS and Parkinson’s disease, particularly through targeting misfolded protein species believed to drive disease pathology.'"

Preclinical • Amyotrophic Lateral Sclerosis • Parkinson's Disease